Disclosures: Grace Lai-Hung Wong: AstraZeneca, Gilead Sciences, GlaxoSmithKline and Janssen,: Advisor, Abbott, AbbVie, Ascletis, Bristol-Myers Squibb, Echosens, Gi: Speaking and Teaching, Gilead Sciences: Grant/Research Support, Mario Alvares-da-Silva: Nothing to Disclose, Fatima Higuera-de-la-Tijera: Nothing to Disclose, Ming-Lung Yu: Abbvie, Gilead and Roche diagnostics.: Grant/Research Support, Abbott, Abbvie, Gilead, Roche and Roche diagnostics: Consultant, Abbvie, BMS, Gilead, Roche and Roche diagnostics: Speaking and Teaching, Soo Aleman: Gilead: Speaking and Teaching, Francisco Javier Garca-Samaniego Rey: Gilead
Importantly, weight loss may restore ovulatory function and fertility in some women with obesity-related menstrual irregularities or PCOS, which has implications for both sexual health and contraception planning
Yes, when administered under medical supervision, GLP-1 medications like Semaglutide are safe, effective, and FDA-approved for weight loss
Bruising
studies in kidney tissue and in animal models showed a reduction of NF-kB activity after the administration of exendin-4 [43, 44]
The US Peptide Therapeutics Market has been projected at $52.6 billion in 2025 by Holt Law's market report, reflecting the combined scope of GLP-1 and non-GLP-1 peptide pipeline commercialisation pressure
)
